| Revenue | 42.28M |
| Cost of revenue | 34.44M |
| Gross profit | 7.83M |
| Operating expenses (income): | |
| Selling, general, and administrative | 6.77M |
| Research and development | 4.11M |
| Litigation settlements, net | |
| Total operating expenses | -4.34M |
| Operating loss | 12.17M |
| Other income (expense): | |
| Interest income | |
| Interest expense | |
| Foreign exchange gain (loss) | -21K |
| Loss from equity method investment | 0 |
| Change in fair value of financial instruments | -267K |
| Other expense | |
| Total other income (expense) | -474K |
| Net loss | 11.7M |
| Foreign exchange translation adjustment | |
| Comprehensive loss | 11.62M |
| Per share data: | |
| Net loss per basic share | 0.44 |
| Net loss per diluted share | 0.44 |
| Weighted-average number of basic shares outstanding | 26.31M |
| Weighted-average number of diluted shares outstanding | 26.64M |